Careviso has raised over $17 million in Series B funding led by Ballast Point Ventures alongside insiders Mercury and Lytical Ventures, the health care transparency startup tells Axios exclusively.
Why it matters: The costs and administrative requirements associated with health care diagnostics have historically been opaque and difficult to understand, with the consequences felt by both physicians and patients.
